PACE Talks

Prof. John Betteridge and prof. Chris Packard talk about HDL as the next target in terms of a global approach to lipid and lipoprotein management. The epidemiology is strong that low HDL is a very important risk factor.

Prof. John Betteridge and prof. Chris Packard talk about HDL as the next target in terms of a global approach to lipid and lipoprotein management.